세계의 해양 바이오테크놀러지 시장 - 산업 규모, 점유율, 동향, 기회, 예측 : 유형별, 기술별, 용도별, 최종 사용자 업계별, 지역별, 경쟁별(2020-2030년)
Marine Biotechnology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Technology, By Application, By End User Industry, By Region and Competition, 2020-2030F
상품코드:1785189
리서치사:TechSci Research
발행일:2025년 08월
페이지 정보:영문 185 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 해양 바이오테크놀러지 시장 규모는 2024년에 63억 5,000만 달러로 평가되었고, 예측 기간 중의 CAGR은 7.08%를 나타낼 전망이며, 2030년에는 95억 7,000만 달러에 달할 것으로 예상되고 있습니다.
세계의 해양 바이오테크놀러지 시장은 해초 관련 제품과 같은 해양 유래 천연 제품에 대한 수요가 증가하고 지속 가능한 천연 제품 개발에 대한 투자가 증가함에 따라 큰 성장을 이루고 있습니다. 게다가 어업, 창약, 수산 양식 분야에서의 진보가 증가하고 있으며, 예측 기간 동안 시장 성장을 뒷받침할 것으로 기대되고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
63억 5,000만 달러
시장 규모 : 2030년
95억 7,000만 달러
CAGR : 2025-2030년
7.08%
급성장 부문
배양 독립적 기술
최대 시장
북미
또한, 고품질의 의료를 제공하기 위한 다양한 효율적인 치료제에 대한 수요 증가는 예측 기간 동안 해양 바이오테크놀러지 시장의 추가 추진력이 되고 있습니다. 해양 기반 의약품은 심혈관 질환과 신경 장애와 같은 다양한 만성 질환을 치료하기 위해 개발되었습니다. 또한 소비자의 의식이 높아지고 친환경 제품을 중시하는 경향이 강해지고 있는 것도 해양 바이오테크놀러지에 대한 수요를 더욱 높이고 있습니다.
주요 시장 성장 촉진요인
지속 가능한 바이오 제품에 대한 수요 증가
주요 시장 과제
규제와 법적 틀의 복잡성
주요 시장 동향
해양 유래의 의약품과 영양 보조 식품의 확대
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 목소리
제5장 세계의 해양 바이오테크놀러지 시장 전망
시장 규모와 예측
금액별
시장 점유율·예측
유형별(생리활성 물질 대 생체 물질)
기술별(미생물 분리 및 배양 대 배양 독립적 기술)
용도별(양식 및 식품, 환경 및 인체 건강, 신약 개발, 기타)
최종 사용자 업계별(바이오테크놀러지 및 제약, 화학, 화장품, 기타)
지역별
기업별(2024년)
시장 맵
유형별
기술별
용도별
최종 사용자 업계별
지역별
제6장 북미의 해양 바이오테크놀러지 시장 전망
시장 규모와 예측
시장 점유율·예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 해양 바이오테크놀러지 시장 전망
시장 규모와 예측
시장 점유율·예측
유럽 : 국가별 분석
프랑스
독일
영국
이탈리아
스페인
제8장 아시아태평양의 해양 바이오테크놀러지 시장 전망
시장 규모와 예측
시장 점유율·예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 남미의 해양 바이오테크놀러지 시장 전망
시장 규모와 예측
시장 점유율·예측
남미 : 국가별 분석
브라질
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 해양 바이오테크놀러지 시장 전망
시장 규모와 예측
시장 점유율·예측
중동 및 아프리카 : 국가별 분석
남아프리카
사우디아라비아
아랍에미리트(UAE)
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
최근 동향
합병과 인수
제품 출시
제13장 해양 바이오테크놀러지 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계 내 경쟁
신규 진입의 가능성
공급자의 힘
고객의 힘
대체품의 위협/서비스
제15장 경쟁 구도
Lonza Group
Sea Run Holdings Inc
PharmaMar SA
Cyanotech Corporation
New England Biolabs Inc.
Qingdao Codo International Ltd
Nutrex Hawai Inc.
Royal DSM NV
Prolume Ltd.
CP Kelco US Inc.
제16장 전략적 제안
제17장 기업 소개와 면책사항
KTH
영문 목차
영문목차
Global Marine Biotechnology Market was valued at USD 6.35 billion in 2024 and is expected to reach USD 9.57 billion by 2030 with a CAGR of 7.08% during the forecast period. The global market for Marine Biotechnology is experiencing significant growth, driven by growing demand for natural products from marine derived like seaweed related products and increasing investments in the development of sustainable and natural products. Additionally, increasing advancement in the areas of fisheries, drug discovery and aquaculture are expected to boost market growth in the forecast period.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 6.35 Billion
Market Size 2030
USD 9.57 Billion
CAGR 2025-2030
7.08%
Fastest Growing Segment
Culture-Independent Techniques
Largest Market
North America
Additionally, increasing demand for different efficient therapeutics to deliver quality care is further propel the marine biotechnology market in the forecast period. Marine derived drugs are developed for the treatment of different chronic diseases such as cardiovascular disease, neurological disorder. Besides, growing consumer awareness and increasing emphasis on eco-friendly products is further enhancing the demand of marine biotechnology.
Key Market Drivers
Growing Demand for Sustainable Bio-based Products
The increasing global emphasis on sustainability and environmentally friendly alternatives is a significant driver for the marine biotechnology market. Marine organisms provide a vast and largely untapped source of bioactive compounds, enzymes, and polymers, which are being increasingly utilized in pharmaceuticals, nutraceuticals, cosmetics, and industrial applications. These natural, biodegradable materials offer a viable alternative to petroleum-based products, aligning with global sustainability goals.
Government support for bio-based economies further fuels this demand. For instance, the European Union's Bioeconomy Strategy, revised in 2018, places strong emphasis on utilizing renewable biological resources sustainably, including marine resources. The EU Blue Bioeconomy Report highlights how marine biotechnology supports sustainable growth and the circular economy, with funding initiatives such as the Horizon Europe program allocating billions of euros toward marine bioeconomy research and innovation.
Additionally, the U.S. Department of Energy (DOE) has supported research into marine algae for biofuel production under its Bioenergy Technologies Office (BETO). BETO-funded programs such as the Algae Technology Education Consortium (ATEC) aim to develop the U.S. algae workforce and support bio-product development. Marine biotechnology is thus seen as pivotal to national strategies for climate change mitigation, resource security, and economic development.
The rise in consumer awareness about the environmental impact of synthetic chemicals and plastics is also driving demand for marine-derived alternatives. As industries continue to seek sustainable raw materials, marine biotechnology stands to benefit, making it a key component of the global transition to a greener economy.
Key Market Challenges
Regulatory and Legal Framework Complexities
One of the most pressing challenges in the global marine biotechnology market is navigating the complex and fragmented regulatory landscape governing access to marine genetic resources. Marine bioprospecting often involves sampling from international waters or exclusive economic zones (EEZs), leading to jurisdictional ambiguities and compliance issues under international law. The Nagoya Protocol on Access and Benefit-sharing (ABS) under the Convention on Biological Diversity (CBD) aims to regulate the use of genetic resources and ensure fair benefit-sharing. However, its implementation varies significantly across countries, causing uncertainty for marine biotech companies. For instance, some countries enforce strict ABS laws that require long and bureaucratic approval processes, while others have more lenient or unclear regulations.
Moreover, marine biotechnology activities often intersect with maritime laws, environmental protection regulations, and ethical concerns over the exploitation of marine biodiversity. This complexity can delay research, restrict access to biological samples, and hinder international collaboration. In areas beyond national jurisdiction (ABNJ), legal frameworks for access and benefit-sharing remain under negotiation under the UN Convention on the Law of the Sea (UNCLOS). Governments are working to address these gaps. The 2023 UN High Seas Treaty, adopted to protect biodiversity in ABNJ, aims to establish clearer rules for marine genetic resource usage. However, practical implementation will take time, and industry stakeholders still face regulatory uncertainty in the interim.
Key Market Trends
Expansion of Marine-Derived Pharmaceuticals and Nutraceuticals
The growing recognition of marine organisms as sources of novel bioactive compounds is reshaping the pharmaceutical and nutraceutical industries. Marine-derived compounds have shown promising therapeutic potential, particularly in areas such as anti-inflammatory, anticancer, antimicrobial, and neuroprotective treatments. This is driving increased investment in marine-based drug discovery and nutraceutical development.
Marine-derived drugs such as Ziconotide, developed from cone snail venom for chronic pain, and Trabectedin, derived from sea squirts for cancer treatment, have demonstrated the clinical and commercial viability of marine bioproducts. According to the U.S. Food and Drug Administration (FDA), multiple marine-origin compounds are in various stages of clinical trials, indicating the growing interest in marine pharmaceuticals. Governments are also increasingly promoting the exploration of marine biodiversity for medical applications. The European Marine Biological Resource Centre (EMBRC-ERIC), supported by the European Commission, facilitates access to marine biodiversity and research infrastructure to accelerate drug discovery. Similarly, India's Department of Biotechnology has launched the Marine Bioresource and Biotechnology (MBB) program under its "Blue Economy" initiatives to support the development of marine-derived pharmaceuticals.
On the nutraceutical front, the demand for marine omega-3 fatty acids, astaxanthin, and marine collagen is rising due to their health benefits. Regulatory bodies such as the European Food Safety Authority (EFSA) and the U.S. FDA have established frameworks that support the marketing of these marine-based functional ingredients.
Key Market Players
Lonza Group
Sea Run Holdings Inc
PharmaMar S.A.
Cyanotech Corporation
New England Biolabs Inc.
Qingdao Codo International Ltd
Nutrex Hawai Inc.
Royal DSM N.V.
Prolume Ltd.
CP Kelco US Inc.
Report Scope:
In this report, the Global Marine Biotechnology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Marine Biotechnology Market, By Type:
Bioactive Substance
Biomaterials
Marine Biotechnology Market, By Technology:
Isolation and Cultivation of Microorganisms
Culture-Independent Techniques
Marine Biotechnology Market, By Application:
Aquaculture and Food Products
Environment & Human Health
Drug Discovery
Others
Marine Biotechnology Market, By End User Industry:
Biotechnology & Pharmaceuticals
Chemicals
Cosmetic
Others
Marine Biotechnology Market, By Region:
North America
United States
Mexico
Canada
Europe
France
Germany
United Kingdom
Italy
Spain
Asia-Pacific
China
India
South Korea
Japan
Australia
South America
Brazil
Argentina
Colombia
Middle East and Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Marine Biotechnology Market.
Available Customizations:
Global Marine Biotechnology Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Marine Biotechnology Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Bioactive Substance v/s Biomaterials)
5.2.2. By Technology (Isolation and Cultivation of Microorganisms v/s Culture-Independent Techniques)
5.2.3. By Application (Aquaculture and Food Products, Environment & Human Health, Drug Discovery, Others)
5.2.4. By End User Industry (Biotechnology & Pharmaceuticals, Chemicals, Cosmetic, Others)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
5.3.1. By Type
5.3.2. By Technology
5.3.3. By Application
5.3.4. By End User Industry
5.3.5. By Region
6. North America Marine Biotechnology Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Technology
6.2.3. By Application
6.2.4. By End User Industry
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Marine Biotechnology Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Technology
6.3.1.2.3. By Application
6.3.1.2.4. By End User Industry
6.3.2. Canada Marine Biotechnology Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Technology
6.3.2.2.3. By Application
6.3.2.2.4. By End User Industry
6.3.3. Mexico Marine Biotechnology Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Technology
6.3.3.2.3. By Application
6.3.3.2.4. By End User Industry
7. Europe Marine Biotechnology Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Technology
7.2.3. By Application
7.2.4. By End User Industry
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. France Marine Biotechnology Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Technology
7.3.1.2.3. By Application
7.3.1.2.4. By End User Industry
7.3.2. Germany Marine Biotechnology Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Technology
7.3.2.2.3. By Application
7.3.2.2.4. By End User Industry
7.3.3. United Kingdom Marine Biotechnology Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Technology
7.3.3.2.3. By Application
7.3.3.2.4. By End User Industry
7.3.4. Italy Marine Biotechnology Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Technology
7.3.4.2.3. By Application
7.3.4.2.4. By End User Industry
7.3.5. Spain Marine Biotechnology Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Technology
7.3.5.2.3. By Application
7.3.5.2.4. By End User Industry
8. Asia-Pacific Marine Biotechnology Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Technology
8.2.3. By Application
8.2.4. By End User Industry
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Marine Biotechnology Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Technology
8.3.1.2.3. By Application
8.3.1.2.4. By End User Industry
8.3.2. India Marine Biotechnology Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Technology
8.3.2.2.3. By Application
8.3.2.2.4. By End User Industry
8.3.3. Japan Marine Biotechnology Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Technology
8.3.3.2.3. By Application
8.3.3.2.4. By End User Industry
8.3.4. South Korea Marine Biotechnology Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Technology
8.3.4.2.3. By Application
8.3.4.2.4. By End User Industry
8.3.5. Australia Marine Biotechnology Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Technology
8.3.5.2.3. By Application
8.3.5.2.4. By End User Industry
9. South America Marine Biotechnology Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Technology
9.2.3. By Application
9.2.4. By End User Industry
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Marine Biotechnology Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Technology
9.3.1.2.3. By Application
9.3.1.2.4. By End User Industry
9.3.2. Argentina Marine Biotechnology Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Technology
9.3.2.2.3. By Application
9.3.2.2.4. By End User Industry
9.3.3. Colombia Marine Biotechnology Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Technology
9.3.3.2.3. By Application
9.3.3.2.4. By End User Industry
10. Middle East and Africa Marine Biotechnology Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Technology
10.2.3. By Application
10.2.4. By End User Industry
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Marine Biotechnology Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Technology
10.3.1.2.3. By Application
10.3.1.2.4. By End User Industry
10.3.2. Saudi Arabia Marine Biotechnology Market Outlook
